PS-series
carbapenems such as PS-52), PS-63), PS-73) and PS-84) are structurally characterized by their side chains at C-3 and C-6 ( Fig. 1) . Like other naturally-occurring carbapenem compounds, PS-5 is also physico-chemically unstable and susceptible to dehydropeptidase-I (DHP-I) in vitro5) and in vivo6\ resulting in poor urinary recovery after parenteral administration. PS-5 is antimicrobially inferior to thienamycin in anti-pseudomonal activity. As is the case with the penicillin and cephalosporin antibiotics, however, the above clinical disadvantages of PS-5 and related carbapenem compounds may be overcome by chemical and biological modifications. To pursue this line of approach, a practically useful synthetic process named "the sulfoxide method" has been developed. It consists of treatment of carbapenem ester sulfoxides with a variety of thiol compounds, and it offers an efficient replacement of the C-3 side chain of carbapenem compounds (Fig. 2) 7'8).
This paper describes the structure-antimicrobial activity relationships of 34 PS-5 carbapenem derivatives which were prepared by the sulfoxide method and its modification, with particular reference to the antibacterial activity against Gram-positive and Gram-negative bacteria including /Mactamaseproducing strains.
Results and Discussion
Structures and Derivation Yields of PS-5 Derivatives Table 1 shows the side chain structures and derivation yields of PS-5 derivatives modified at the C-3 side chain.
For ease of comparison, the 35 PS-5 derivatives are divided into 4 groups depending on the common structures of the C-3 side chain, and their antibacterial activities were examined against Gram-positive and Gram-negative test microorganisms including /Mactamase-producers. Table 1 . Recovery yields of S-substituted carbapenem derivatives. OCT. 1990 Ester ( In Table 2 , a common structure of "-S-CH2-CH2" in the C-3 side chain of PS-5 is modified with a variety of substituents. Compared with acetamidoethylthio in PS-5 (parent; derivative 1), the elongation of the commonstructure by ethyl (derivative 2) results in overall reduction of the antibiotic potency. The introduction of a hydroxyl function (derivative 3) has no influence on the antibacterial activity against the Gram-positive microbes, but slightly reduces the activity against the Gram-negative microbes.
Carboxylation (derivative 4) decreases the antibacterial activity against not only the Gram-positive but also the Gram-negative microorganisms. Derivative 5 (deacetyl PS-5 or NS-5) is chemically comparable to thienamycin, as both have a free amino group at the terminus of the C-3 side chain. Like thienamycin, NS-5 has better antibacterial activity than PS-5 against the Gram-positive bacteria, because of higher basicity. It is interesting to indicate that, as far as the Gram-negative microbes are concerned, only the anti-pseudomonal activity is improved by deacetylation of PS-5, while the other test microbes show less susceptibility, presumably because NS-5 becomes physico-chemically more labile than PS-5, as is reported for MM4550 (sulfoxide)9). Dimethylation of NS-5 (derivative 6), however, results in diminished antibiotic activity. Phenylacetylation (derivative 7) and phosphorylation (derivative 8) of NS-5 reduce the antibacterial activity against the Gram-negative microbes only. As is observed with NS-5, the introduction of a 4-pyridyl group (derivative 9) improves the antibacterial activity against the Gram-positive pathogens owing to elevated basicity, while its activity falls against the Gram-negative bacteria including the pseudomonads. Table 3 deals with "-S-CH2-CH(NHX)-" as common structure of the C-3 side chain of PS-5. Replacement of the acetamidoethylthio side chain (PS-5; derivative 1) by optically active cysteines (derivatives 10 and ll) leads to the significantly reduced activities against the Gram-positive microbes, while the improved activity against the Gram-negative bacteria is higher with the D-cysteinyl side chain (derivative ll) than with the L-cysteinyl (derivative 10). Accordingly, all the rest derivatives in Table 3 have the amino group in the (^-configuration. The introduction of a hydroxymethyl group (derivative 12) into NS-5 (derivative 5) results in the diminished antibacterial activity. Amidation (derivative 13) and pyridylamidation (derivative 14) of the terminal carboxyl in the C-3 side chain of derivative ll improves the antibacterial activity against the Gram-positive bacteria, but reduces the activity against the Gram-negative microbes. Dimethylation (derivative 15), acetylation (derivative 16) and wo-nicotinylation (derivative 17) of the free amino group of derivative ll clearly cause the activity to drop. Coupling of derivative ll with 6-aminopenicillanate (derivative 18) decreases the antibiotic activity, particularly against the Gram-negative bacteria. Dimethylation of the C-3 side chain at C-l l (derivative 19) also diminishes antibacterial activity.
It is noteworthy that the configuration of the amino group of the C-3 side chain (derivatives 10 and ll) is important not only for expression of antimicrobial activity, but also stabilization to DHP-I (see a separate paper)10). Table 4 contains the PS-5 derivatives which have "-S-CH2-" as commonstructure of the C-3 side chain. In structural comparison with the C-3 side chain of PS-5, no plausible explanation is available about the good antibacterial activity of derivative 20 against the Gram-positive test microbes, while its activity against the Gram-negative organisms falls. The introduction of basic groups such as imidazolyl, hydroxypyridyl and aminopyridylcarbamoyl (derivatives 21, 22 and 24) leads to improved antibacterial activity against the Gram-positive pathogens, as is observed above with NS-5 (derivative 5), and to reduced activity against the Gram-negative microorganisms. The other carbapenems (derivatives 23, 25 and 26) show the significantly decreased antibacterial activities against the test microbes. Table 5 exhibits the antibacterial activities of the carbapenem derivatives which are collectively included in the group having no alkyl linkage between the sulfur atom and the substituents in the C-3 side chain. It is interesting to note that this type of the C-3 side chain modification significantly reduces the antibacterial activity against the Gram-negative microbes only, which seems to indicate that a short alkyl linkage between the sulfur atom and the substituents is necessary for expression of the antibacterial activity against the Gram-negative pathogens, whereas the antibacterial activity against the Gram-positive microbes is not affected by its absence.
Antibacterial
Activity against^-Lactamase-producing Bacteria PS-5 is resistant to almost all the /Mactamases known in the literature excluding several metal-containing ones. Furthermore, it inactivates them, leading to strong synergistic antimicrobial activity1} with the penicillins and cephalosporins. All the naturally-occurring carbapenem compounds including PS-5 and thienamycin, on the other hand, are susceptible in vivo and in vitro to DHP-Iby the samemechanismas is observed in the reaction of penicillins and cephalosporins with /Mactamase11*, while DHP-Iattacks no penicillins and cephalosporins at all. Accordingly, it is important to examine the influence of chemically modified C-3 side chains on /Mactamase and DHP-I susceptibilities to see if they differ from those having the acetamidoethylthio group in this position.
The antibacterial activities of carbapenem, penicillin and cephalosporin derivatives on /Mactamaseproducing microorganisms largely depends on the /Mactamase susceptibilities, /Mactamase-inactivating activities, and cell wall and membranepermeability. Except for Bacillus cereus type II /Mactamase12* and Pseudomonas maltophilia /Mactamase13*, no enzymesare knownto inactivate carbapenems.Accordingly it seemed acceptable to postulate that MICswere a useful indicator for /Mactamasesusceptibility. In this paper, the effects of the C-3 side chain modification on /Mactamases were indirectly examined by the antibacterial activity against the /Mactamase-producing Gram-negative microorganisms. In a subsequent paper, the /Mactamase-susceptibility and /Mactamase-inhibitory activity of these and related carbapenem derivatives will be studied in vitro by purified /Mactamase preparations.
To antibacterial activity of PS-5 against /Mactamase-producing Gram-positive bacteria except B. cereus is not influenced by the introduction of a variety of side chains at C-3 (Staphylococcus aureus Russell in Tables 2~5 and unpublished results) .
As is reported by Sawai et al}A\ the /Mactamase-susceptibility and the cell wall and membrane permeability of penicillins and cephalosporins are key factors in expression of their antibiotic activity against /Mactamase-producing Gram-negative microbes. PS-5 (parent compound) shows strong antibacterial activity against the /Mactamase-producing Gram-negative bacteria (Table 2) , suggesting seemingly complete resistance of PS-5 to these /Mactamases in vitro. The C-6 ethyl and C-3 acetamidoethylthio side chains and the stereochemistry at C-6 of PS-5 are known to be very important for expression of its antibacterial activity against Gram-positive and Gram-negative bacteria. An examination of Tables 2~5 reveals that the Enterobacter, Proteus, Pseudomonas and Serratia strains are significantly responsive to the chemical modification of the C-3 side chain of PS-5. For example, in the antimicrobial activity against the 3 Enterobacter strains, derivatives ll and 21 seem to differ from derivatives 4, 7, 10, 18, 20, 22, 23, 26, 29, 30, 31, 32 and 33 . In particular, compared with the acetamidoethylthio side chain of the parent compound, only the D-cysteinyl (derivative ll) and imidazolyl OCT. 1990 (derivative 21) groups increase the specific antibacterial potencies against Enterobacter cloacae 45 and Enterobacter sp. E8. In a similar context, derivatives ll, 30 and 32 may be different from derivatives 7, 8, 22, 25, 27, 29, 31 and 33 in the pattern of influence of the side chain modification on the antibacterial activity against the 4 Proteus species. Synergism of PS-5 with penicillins and cephalosporins in their antibacterial activity against Proteus vulgaris GN76was previously reported. 1}
The two strains of P. aeruginosa showdifferent responses to the modified C-3 side chains (derivatives 5, 7, 14, 21, 27, 28, 31 and 33), presumably indicating that the /Mactamases involved may have distinct substrate profiles. The same observation as above is also seen for derivatives 7, 10, ll, 20 and 24 against the twostrains of Serratia marcescens. PS-5 is a potent inhibitor of a variety of /Mactamases15'16*, so it seemed reasonable to assume that binding of PS-5 with 6-aminopenicillanate (6-APA) and 7-aminocephalosporanate (7-ACA) with a covalent bond might protect the penicillin and cephalosporin from /Mactamase attack by virtue of the carbapenem. Contrary to the expectation, however, the introduction of PS-5 to 6-APA (derivatives 18 and 25)17) and 7-ACA(derivative 25) seems to result in rather increased sensitivity of penicillin and cephalosporin to /Mactamases. Experimental
Preparation of Antibiotics PS-5 (sodium salt) was obtained by fermentation as detailed in a previous paper18). Derivative
(NS-5) was prepared from PS-by microbial deacetylation19).
Thirty-three PS-5 derivatives with modified C-3 side chains were synthesized by the sulfoxide method through Route A or B (Fig. 2) . More particularly, derivatives 21~26 and 31 were prepared through Route B, and the other derivatives through Route A. Of these derivatives, 2~6, 9, 21, 22 and 27~34 were described in a previous report8). Thienamycin (THM)20) was produced by fermentation; and imipenem (IPM)21) and 8861722) were synthesized according to reported procedures. Cefazolin (CEZ) and ampicillin (ABPC)were purchased from Fujisawa Pharmaceuticals Co., Ltd. and Toyo Jozo Co., Ltd., respectively.
Antibacterial Evaluation
Susceptibility testing was performed by the standard agar dilution technique23) using Mueller-Hinton agar and Heart infusion agar (Difco). Overnight cultures of test organisms were diluted in saline. Final inocula of approximately 106 cells/ml were applied on agar mediumby a multipoint spot inoculator. Agar plates were examinedafter 18 hours of incubation at 35°C.
General Methodology
UVand IR spectra were recorded on a Hitachi 200-20 and a Hitachi 260-30 spectrophotometer, respectively. NMRspectra were obtained in CDC13with a Varian EM-390or a Jeol PS-100 spectrometer, using TMSas internal standard, unless otherwise stated. MSdata were obtained with Hitachi EM-80and RMU-7mass spectrometers. Specific rotations were measured with a Jasco DIP-181 digital polarimeter. Pre-coated silica gel plates F254 and Silica gel 60 (70 -300 mesh, E. Merck, Darmstadt) were used for TLC and column chromatography, respectively. All carbapenem /7-nitrobenzyl esters were deprotected by hydrogenation and chromatographed on a column of QAE-Sephadex A-25 or Diaion CHP-20AGfollowed by freeze-drying to yield corresponding carbapenem derivatives.
Chemical Derivation of benzene and washed three times with 0.1 m phosphate buffer, pH 6.8. The organic layer was separated, dried over anhydrous sodium sulfate and filtered. Thefiltrate was concentrated to dryness under reduced pressure to give a pale-yellow oily product. The product was dissolved in a small volume of methylene chloride and passed through a column of silica gel (20g) which had been wetted with a solvent mixture of benzene and acetone (1 : 1). The product was developed with the same solvent system. From the eluate 134mg of the title compound (79% yield) was recovered. On a silica gel TLC plate this derivative showed an Rf value of 0.66 with a solvent system of benzene-acetone (1 :2 2-ene-2-carboxylate (120mg) was dissolved in a solvent mixture of 10.2ml of THFand 9.4ml of 0.1 m phosphate buffer, pH 7.0, and then hydrogenated in the presence of 170mg of Adamscatalyst at room temperature for 5 hours in a Paar apparatus (hydrogen pressure 4 kg/cm2). The catalyst was removed by filtration and washed with 0.01 m phosphate buffer, pH 6.8. The filtrate and the phosphate wash were combined. The solution was applied on a column of QAE-SephadexA-25 (1.1 x 20cm) and developed with a linear concentration gradient of sodium chloride in 0.01 m phosphate buffer, pH 6.8, from 0 to 0.4 m. Each eluate fraction was monitored with a spectrophotometer and fractions having an absorption maximum at 300 nmwere combined.After 2%sodiumchloride was added, the solution was charged on a column of Diaion CHP-20AG(1.1 x 20 cm). Elution was carried out with a linear concentration gradient of acetone in water from 0 to 30% (total eluant 200ml). Eluate fractions possessing a UVabsorption maximumat 300nm were collected and freeze-dried to give 31.8 mg of the target derivative (yield 34%). chloride in 2ml of DMFwere added dropwise to the said reaction mixture at -20°C. After the same work-up as described for derivative 7, the crude product was subjected to purification by silica gel column chromatography using a solvent system of benzene and acetone (2 : 1). By silica gel TLC monitoring with a developing solvent mixture of benzene and acetone m, m, 3.97 (1H, dt, 7=3 and 9Hz, . m, 3.82 (1H, dt, 7=3 and 9Hz, (1H, m, 2'-H), 5.14 (1H, d, 7=13.5Hz, -OCHH-Ar), 5.18 (2H, s, -OC#2-Ar), 5.43 (1H, d, 7=13.5Hz, -OCH#-Ar), 6.40 (1H, d, 7=8Hz, NH), 7.00 (1H, dd, 7=5 and 7.5Hz, 7.41 (2H, d, 7=9Hz, Ar), 7.53 (2H, d, 7=9Hz, Ar), m, 8.10 (4H, d, 7=9Hz, Ar), m, 6 ' -H), 9.47 (1H, br, NH). 3-[(2*S)-2-Amino-2-A^-(pyridin-2-yl)carbamoyl]ethylthio -6-ethyl-7-oxol -azabicyclo[3.2.0] m, 3.45 (1H, dd, 7=7 and 8Hz, 3.95 (1H, dt, 7=3 and 9Hz, 5.17 (1H, d, 7=13Hz ester S-oxide (20mg) was dissolved in 10ml of dry DMFand cooled to -35°C. To the solution, 0.36ml of sodium bisulfide hydrate in DMF(lOmg/ml of NaSH xH2O) was slowly added under agitation and stirred for 10minutes at -35°C. Then 25 fd of triethylamine was added to the solution and warmedto room temperature. /?-Nitrobenzyl 6-chloroacetylaminopenicillanate (22.8 mg) in 1.5ml of DMFwas gradually added into the said solution arid allowed to react for 2 hours under agitation. The reaction mixture was poured in 150ml of benzene and then washed with 0.1 M phosphate buffer, pH 6.8 (60ml x 3). The benzene phase was dried over anhydrous sodium sulfate and condensed to 1.5 ml in vacuo. The condensate was charged on a silica gel column (20 g). The elution was performed with a solvent mixture of benzene and acetone (10 : 1). By silica gel TLCmonitoring with a solvent system of benzene and acetone (5 : 1), eluate fractions were collected which contained a UV-absorbing material at
